The FDA wants to make the public, including health care providers, aware of biotin interference with lab tests so that patients, physicians, and laboratories can work together to help prevent adverse events.pic.twitter.com/ng8kEscf6O

The FDA wants to make the public, including health care providers, aware of biotin interference with lab tests so that patients, physicians, and laboratories can work together to help prevent adverse events. pic.twitter.com/ng8kEscf6O
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news